Renicus S. Hermanides

Nieuwegein, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications

Long-term clinical outcomes of high-risk plaques with negative fractional flow reserve: the PECTUS-obs study.

Long-term clinical outcomes of high-risk plaques with negative fractional flow reserve: the PECTUS-obs study.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: May 27, 2026

Long-Term Clinical Outcomes of High-Risk Plaques with Negative fractional flow reserve: the PECTUS-obs study.

Long-Term Clinical Outcomes of High-Risk Plaques with Negative fractional flow reserve: the PECTUS-obs study.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: May 27, 2026

Impact of Early Nonfatal Complications After Transcatheter Aortic Valve Implantation on 1-Year Mortality and Quality of Life: Insights From the LANDMARK Trial.

Impact of Early Nonfatal Complications After Transcatheter Aortic Valve Implantation on 1-Year Mortality and Quality of Life: Insights From the LANDMARK Trial.

Journal: Structural heart : the journal of the Heart Team
Published: March 07, 2026

Pacemaker recovery after permanent pacemaker implantation post-transcatheter aortic valve implantation: A sub-study of the LANDMARK trial.

Pacemaker recovery after permanent pacemaker implantation post-transcatheter aortic valve implantation: A sub-study of the LANDMARK trial.

Journal: International journal of cardiology
Published: February 23, 2026

Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction.

Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction.

Journal: NEJM evidence
Published: November 10, 2025

Impact of clinical risk characteristics on the prognostic value of high-risk plaques.

Impact of clinical risk characteristics on the prognostic value of high-risk plaques.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: October 06, 2025

VARC-HBR criteria validation in TAVI patients on oral anticoagulation.

VARC-HBR criteria validation in TAVI patients on oral anticoagulation.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: September 17, 2025

Taking sustainability of cardiac catheterization to the next level: the Hartplastic showcase.

Taking sustainability of cardiac catheterization to the next level: the Hartplastic showcase.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
Published: August 21, 2025

1-Year Outcomes of Novel Balloon-Expandable vs Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis: The LANDMARK Trial.

1-Year Outcomes of Novel Balloon-Expandable vs Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis: The LANDMARK Trial.

Journal: Journal of the American College of Cardiology
Published: July 21, 2025

Quantitative videodensitometric assessment of aortic regurgitation in Myval, Sapien, and Evolut THV series: Results from the LANDMARK trial.

Quantitative videodensitometric assessment of aortic regurgitation in Myval, Sapien, and Evolut THV series: Results from the LANDMARK trial.

Journal: International journal of cardiology. Heart & vasculature
Published: June 02, 2025

Efficacy and Safety of Low-Dose Rivaroxaban in High-Ischemic-Risk Patients with Chronic Coronary Syndrome: Rationale and Design of the DUTCH CCS Registry.

Efficacy and Safety of Low-Dose Rivaroxaban in High-Ischemic-Risk Patients with Chronic Coronary Syndrome: Rationale and Design of the DUTCH CCS Registry.

Journal: Journal of clinical medicine
Published: April 18, 2025

Comparative 30-day echocardiographic outcomes of Myval vs. Sapien and Evolut THVs: insights from LANDMARK trial.

Comparative 30-day echocardiographic outcomes of Myval vs. Sapien and Evolut THVs: insights from LANDMARK trial.

Journal: European heart journal. Cardiovascular Imaging
Published: April 13, 2025
Showing 1-12 of 96

Last Updated: 09/26/2026